Access cutting-edge immune thrombocytopenia treatment through this clinical trial at a research site in Albany. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Albany location
Preparing your pre-screening questions…
Access immune thrombocytopenia specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related immune thrombocytopenia treatment provided free
Check if you qualify for this immune thrombocytopenia clinical trial in Albany, NY
No-Cost Study Care
Local to Albany
Convenient for NY residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This is a multinational, open label, single arm study that will evaluate the impact of early multi-immune modulation with rilzabrutinib in adult ITP patients who failed first-line treatment. The study includes a screening period (up to 8 weeks), a primary analysis period (up to 28 weeks), a long-term extension period for selected participants (28 weeks) and a 24-week follow-up period only for eligible participants.
Sponsor: Sanofi
Yes, this clinical trial (NCT07007962) has an active research site in Albany, NY that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for immune thrombocytopenia treatment options in Albany, NY, this clinical trial (NCT07007962) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Albany research site is actively enrolling participants for this clinical trial. You'll receive care from experienced immune thrombocytopenia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all immune thrombocytopenia clinical trials near you to find additional studies recruiting in your area.
See all multiple myeloma clinical trials recruiting in Albany — not just this study.
Browse Multiple Myeloma Trials in Albany →